MarketPeel
Insider Trading Intelligence
Pricing
…
VL

Vedanta Partners, Llc

RVPH
10% OWNER · REVIVA PHARMACEUTICALS HOLDINGS, INC. · CIK 0001502216
FILING MIX · LIFETIME100%/0%
BUYS
10
SELLS
0
TOTAL VALUE
$8.49M
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
585,366
AVG SELL PX
—
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Vedanta Partners, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+100.00%+5.15%-0.97%+6.12%+6.12%—
14d8+0.00%-9.24%-2.50%-6.74%-6.74%—
30d8+50.00%+2.75%-3.06%+5.80%+5.80%—
60d8+50.00%+68.43%+0.06%+68.37%+68.37%—
90d8+50.00%+29.43%+3.36%+26.07%+26.07%—
180d8+50.00%+35.83%+5.88%+29.95%+29.95%—
1y8+50.00%+22.72%+5.99%+16.73%+16.73%—
2y8+50.00%-2.27%+21.33%-23.60%-23.60%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RVPH · 585,366 shares · as of Nov 20, 2023
0232,750465,500698,250931,00020222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
FLOW · 10 buys / 0 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
585,366——585,366Nov 20, 2023Nov 22, 2023 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
585,366——585,366Nov 20, 2023Nov 22, 2023 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
869,565$0.00$87869,565Sep 8, 2022Sep 12, 2022 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
513,834$2.53$1.30M513,834Sep 8, 2022Sep 12, 2022 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
513,834$0.00$51513,834Sep 8, 2022Sep 12, 2022 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
869,565$2.53$2.20M869,565Sep 8, 2022Sep 12, 2022 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
931,000——931,000Jun 1, 2021Jun 3, 2021 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
399,000$3.75$1.50M399,000Jun 1, 2021Jun 3, 2021 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
931,000$3.75$3.49M931,000Jun 1, 2021Jun 3, 2021 ↗View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
399,000——399,000Jun 1, 2021Jun 3, 2021 ↗View →
Other insiders · RVPH
Loading peer insiders…
About this filer
CIK 0001502216
ROLE
10% Owner
PRIMARY
RVPH
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001502216DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback